Lab Corp. (LH) Receives FDA Emergency Use Authorization for COVID-19 Sample Pooling
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Harry and Meghan surprised by King Charles' letter on their status
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Lab Corp. (LH) Tops Q2 EPS by $1.58, Revenues Beat
July 28, 2020 6:51 AM EDTLab Corp. (NYSE: LH) reported Q2 EPS of $2.57, $1.58 better than the analyst estimate of $0.99. Revenue for the quarter came in at $2.8 billion versus the consensus estimate of $2.5 billion.
Q2 revenue of $2.8 billion, down (4%) from $2.9 billion last yearQ2 diluted EPS of $2.37, up 23% from $1.93 last year; Q2 adjusted EPS of $2.57, down (12%) from $2.93 last yearQ2 free cash flow of $272 million, up from $168 million last yearProcessed more than 8.5 million molecular COVID-19 tests to date, increased capacity to approximately 180 thousand tests per day, and delivering results on average in 2 to 3 days with faster results for hospitalized... More